Recruiting PHASE4 Arm

New treatment option for Arm

Official title The Effect of Dexamethasone Administration Route in Pediatric Brachial Plexus Block

ClinicalTrials.gov ID: NCT07061678

What this study is testing

What is perineural dexamethasone?

perineural dexamethasone is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for arm.

Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.

What it's testing
This study aims to assess the impact of the administration route of dexamethasone (intravenous vs. perineural) on postoperative pain and inflammatory response in pediatric patients undergoing hip surgery.
  • Phase 4: studies an already-approved treatment
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 3 to 6

You may be able to join if

  • children scheduled for arm/wrist/hand surgery
  • body weight \> 5kg

You likely can't join if

  • infection at the site of the regional block,
  • coagulation disorders,
  • immunodeficiency,
  • American Society of Anesthesiologists (ASA) physical status of IV or higher,
  • history of regular steroid medication.

The study team makes the final eligibility decision.

Where it's taking place

  • Poznan, Poland

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 3 months to 6 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Poznan, Poland. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.